Finance

Lists
BIOV:CNSX
Biovaxys Technology Corp
0,070 CAD
0,00%
(0,00) 1D
5-май, 15:55:53 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for BIOV...
Mkt. cap
3,09 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,29 CAD
52-wk low
0,03 CAD
Mkt. cap
3,09 млн
Avg. vol.
0,00
Volume
0,00
52-wk high
0,29 CAD
52-wk low
0,03 CAD
News stories
From web sources and news partners
About Biovaxys Technology Corp
CEO-
Employees-
Founded-
HeadquartersТоронто, Онтарио, Канада
SectorPharmaceutical industry
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2024-ж. окт.
2025-ж. янв.
2025-ж. апр.
2025-ж. июл.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,50 миң
32,95 миң
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,20 млн
1,03 млн
1,08 млн
859,08 миң
Operating expense
1,49 млн
1,14 млн
1,22 млн
859,08 миң
Total operating expenses
1,49 млн
1,14 млн
1,22 млн
859,08 миң
Operating income
-1,49 млн
-1,14 млн
-1,22 млн
-859,08 миң
Other non operating income
-8,90 миң
-68,18 миң
-67,98 миң
-50,97 миң
EBT including unusual items
-2,74 млн
-1,07 млн
-1,32 млн
-910,06 миң
EBT excluding unusual items
-1,50 млн
-1,25 млн
-1,30 млн
-910,06 миң
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2,74 млн
-1,07 млн
-1,32 млн
-910,06 миң
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору